Table 2 Relationship between NEIL3 expression and clinicopathology in our LUAD cohort
From: NEIL3 may act as a potential prognostic biomarker for lung adenocarcinoma
| Characteristics | n | NEIL3 | χ2 | P value | |
|---|---|---|---|---|---|
| Low expression | High expression | ||||
| Total | 406 | 228 | 178 | ||
| Age | 1.082 | 0.298 | |||
| ≤ 60 | 146 | 77 (52.74) | 69 (47.26) | ||
| > 60 | 260 | 151 (58.08) | 109 (41.92) | ||
| Gender | 2.814 | 0.093 | |||
| Male | 249 | 148 (59.44) | 101 (40.56) | ||
| Female | 157 | 80 (50.96) | 77 (49.04) | ||
| TNM stage | 1.81 | 0.178 | |||
| I and II | 312 | 169 (54.17) | 143 (45.83) | ||
| III and IV | 94 | 59 (62.77) | 35 (37.23) | ||
| Tumor stage | 14.648 | 0.002* | |||
| I | 203 | 124 (61.08) | 79 (38.92) | ||
| II | 145 | 81 (55.86) | 64 (44.14) | ||
| III | 32 | 8 (25.00) | 24 (75.00) | ||
| IV | 26 | 15 (57.69) | 11 (42.31) | ||
| Metastasis stage | 0.001 | 0.971 | |||
| Negative | 397 | 223 (56.17) | 174 (43.83) | ||
| Positive | 9 | 5 (55.56) | 4 (44.44) | ||
| Node stage | 0.88 | 0.348 | |||
| Negative | 222 | 120 (54.05) | 102 (45.94) | ||
| Positive | 184 | 108 (58.70) | 76 (41.30) | ||